Clinical and mycological responses to fluconazole and fluconazole MIC in oropharyngeal candidiasis in HIV-infected patients.

Clinical and mycological responses to fluconazole and fluconazole MIC in oropharyngeal candidiasis in HIV-infected patients.

INTRODUCTION: OPC is a common opportunistic infection in HIV-infected patients. Although some patients are asymptomatic, progression of the disease may occur leading to esophageal candidiasis. Fluconazole resistant candidiasis has been reported in several international studies. OBJECTIVES: This stu...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Bussaratid, V, Tansupasawasdikul, S, Simpson, A, Pitisuttithum, P, Phonrat, B, Howe, P, White, N
Natura:	Journal article
Lingua:	English
Pubblicazione:	2002

Documenti analoghi

The clinical efficacy of fluconazole in the treatment of vulvovaginal candidiasis
di: V. N. Serov, et al.
Pubblicazione: (2016-12-01)

Use of fluconazole in women of reproductive age with vulvovaginal candidiasis
di: E. A. Mezhevitinova, et al.
Pubblicazione: (2018-09-01)

Therapeutic Response and Antifungal Susceptibility to Fluconazole in Women with Vulvovaginal Candidiasis
di: Zahra Vahedpoor, et al.
Pubblicazione: (2022-04-01)

The resistance to fluconazole in patients with esophageal candidiasis Resistência ao fluconazol em pacientes com candidíase esofágica
di: Ana Botler Wilheim, et al.
Pubblicazione: (2009-03-01)

Formulation and evaluation of fluconazole emulgels for potential treatment of vaginal candidiasis
di: Oriyomi Temitayo Ogedengbe, et al.
Pubblicazione: (2024-03-01)

Fluconazole prophylaxis for prevention of invasive candidiasis in extremely preterm infants
di: Chun Soo Kim
Pubblicazione: (2021-04-01)

Fluconazole and Ibuprofen Combination: A Potential Treatment for Mucosal Candidiasis
di: Tahere Shamoushaki, et al.
Pubblicazione: (2020-09-01)

Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis
di: Mei Gao, et al.
Pubblicazione: (2016-11-01)

Efficacy of Fluconazole Prophylaxis on Invasive Candidiasis Infection in Extremely Low Birth Weight Neonates
di: Hosein Dalili, et al.
Pubblicazione: (2020-01-01)

Epidemiological profile and fluconazole susceptibility of patients with vulvovaginal candidiasis in northeast Iran
di: Raheleh Alhashem, et al.
Pubblicazione: (2024-01-01)

Sphingolipid Inhibitors as an Alternative to Treat Candidiasis Caused by Fluconazole-Resistant Strains
di: Rodrigo Rollin-Pinheiro, et al.
Pubblicazione: (2021-07-01)

Antifungal Susceptibility Testing to Determine Mic of Amphotericin B, Fluconazole and Ketoconazole Against Ocular Fungal Infection
di: Mitesh H. Patel, et al.
Pubblicazione: (2011-09-01)

Celastrol boosts fluconazole efficacy against vaginal candidiasis: in vitro and in vivo evidence
di: Fatma Al-zahraa A. Yehia, et al.
Pubblicazione: (2025-01-01)

Comparison of the antifungal effect of voriconazole and fluconazole on oral candidiasis before and during radiotherapy
di: Zahra Golestannejad, et al.
Pubblicazione: (2022-01-01)

Understanding fluconazole tolerance in Candida albicans: implications for effective treatment of candidiasis and combating invasive fungal infections
di: Yanru Feng, et al.
Pubblicazione: (2023-12-01)

Efficacy and Safety of Fluconazole Mucoadhesive Patches in Human Immunodeficiency Virus-Related Oral Candidiasis
di: Srikanth Deenadayalan MD, et al.
Pubblicazione: (2024-12-01)

Choosing a systemic antifungal agent for the treatment of vaginal candidiasis: original or generic fluconazole?
di: А. S. Dukhanin
Pubblicazione: (2015-12-01)

A pseudo-randomised clinical trial of <it>in </it>situ gels of fluconazole for the treatment of oropharngeal candidiasis
di: Shetty Veena A, et al.
Pubblicazione: (2011-04-01)

Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia
di: Gebremedhin Beedemariam Gebretekle, et al.
Pubblicazione: (2022-10-01)

Demonstration of Therapeutic Equivalence of Fluconazole Generic Products in the Neutropenic Mouse Model of Disseminated Candidiasis.
di: Javier M Gonzalez, et al.
Pubblicazione: (2015-01-01)

Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis
di: Rençber S, et al.
Pubblicazione: (2016-06-01)

Fluconazole Resistance and Virulence in In Vitro Induced-Fluconazole Resistant Strains and in Clinical Fluconazole Resistant Strain of <i>Cryptococcus deuterogattii</i>
di: Sébastien Bertout, et al.
Pubblicazione: (2023-05-01)

Interchangeability of Fluconazole Drugs
di: N. D. Bunyatyan, et al.
Pubblicazione: (2018-12-01)

Fluconazole Resistant Oral Candidiasis on HIV Patient - What Other Drug can We Choose? A Case Report
di: Dwi Murtiastutik, et al.
Pubblicazione: (2020-03-01)

The Synergism of the Small Molecule ENOblock and Fluconazole Against Fluconazole-Resistant Candida albicans
di: Liping Li, et al.
Pubblicazione: (2019-09-01)

In vitro Susceptibility of Fluconazole, Clotrimazole and Toucrium Polium Smoke Product on Candida Isolates of Vaginal Candidiasis
di: B Bonyadpour, et al.
Pubblicazione: (2009-07-01)

Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients
di: Grau S, et al.
Pubblicazione: (2015-10-01)

Fluconazole induced Stevens-Johnson Syndrome Leading to the Diagnosis of HIV Infection
di: Prafulla Kumar Sharma, et al.
Pubblicazione: (2019-12-01)

Fluconazole Resistance Patterns in Candida Species that Colonize Women with HIV Infection
di: Lulu Zhang, MD, et al.
Pubblicazione: (2014-12-01)

Screening of fluconazole resistance-related genes in Trichosporon asahii with induced fluconazole resistance in vitro
di: XIA Zhikuan1, et al.
Pubblicazione: (2020-05-01)

Fluconazole Prophylaxis of Candida Infections in Preterm Neonates
di: Boselova A, et al.
Pubblicazione: (2019-12-01)

Sensibility Test of Candida species against Nystatin, Ketoconazole, and Fluconazole on Oral Candidiasis with HIV/AIDS using Disc Diffusion Method
di: Cut Shelma Maharani, et al.
Pubblicazione: (2020-11-01)

Confluent And Reticulated Papillomatosis : Treatment Response to Fluconazole
di: Ravikumar B C, et al.
Pubblicazione: (1997-01-01)

Lipase Gene Expression of Resistant and Sensitive Candida Albicans to Fluconazole Isolated from Patients Suffering from Oral Candidiasis and Vaginal Candidiasis
di: Nasrollahi Omran, A, et al.
Pubblicazione: (2015-01-01)

Comparison of the Antifungal Activity of Honey and Fluconazole against Candida albicans in vitro and in an Enteric Candidiasis Mouse Model
di: Mousa Majidi Poya, et al.
Pubblicazione: (2018-12-01)

Coadministration of Ginger Extract and Fluconazole Shows a Synergistic Effect in the Treatment of Drug-Resistant Vulvovaginal Candidiasis
di: Khan A, et al.
Pubblicazione: (2021-04-01)

Basidiobolomycosis Successfully Treated With Fluconazole
di: Bandyopadhyay Debabrata, et al.
Pubblicazione: (1996-01-01)

Fluconazole in the therapy of Pityriasis versicolor
di: Poljački Mirjana N., et al.
Pubblicazione: (2005-01-01)

Study on the mechanisms of action of berberine combined with fluconazole against fluconazole-resistant strains of Talaromyces marneffei
di: Pan Kai-su, et al.
Pubblicazione: (2022-11-01)

Resistencia de levaduras del género Candida al fluconazol Candida yeast´s resistance to fluconazol
di: Carlos Hernando Gómez Quintero
Pubblicazione: (2010-12-01)